The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Imprimis Announces First Quarter 2017 Financial Results May 10, 2017 Meet the 29-Year-Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) January 26, 2017 <b>SerImmune</b> Raises $8M To Map The Human Antibody Repertoire June 19, 2017
Meet the 29-Year-Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) January 26, 2017